IDH2 and central nervous system cancer: On the other hand, the present case harbored IDH2R172K and TP53R248W heterozygous mutation and the DNA methylation array indicated methylation class family glioma, IDH mutant, subclass astrocytoma in primary tumor and high-grade astrocytoma in recurrent tumor.